Ghisallo Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,000	Closed	-$2.2M	–	144
2022 Q4	$2.2M	Buy	+20,000	New	+$2.2M	0.39%	59